Advertisement

Topics

DiaSorin Molecular Receives FDA Clearance for Reliable C. Difficile Assay on LIAISON® MDX Platform

00:00 EDT 12 Sep 2017 | The Laboratory Manager

The new assay runs on the company’s LIAISON® MDX qPCR system, a scalable benchtop instrument that delivers qualitative and quantitative, sample-to-answer, multi-analyte results

Original Article: DiaSorin Molecular Receives FDA Clearance for Reliable C. Difficile Assay on LIAISON® MDX Platform

NEXT ARTICLE

More From BioPortfolio on "DiaSorin Molecular Receives FDA Clearance for Reliable C. Difficile Assay on LIAISON® MDX Platform"

Quick Search
Advertisement
 

Relevant Topic

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...